Independent educational platform. Not a government website and not the Indian Patent Office. Who we are
MYCrave Consultancy & Services PatentActIndia.comA MYCrave Initiative
Patents ActPatents RulesProcessGuidesToolsForms A–ZForms & FeesCase lawCompareWhat happens if…Who is applyingDeadlinesGlossaryWorked examplesUpdatesSearchSite mapAsk a QuestionMy LibraryConsult MYCrave
PATENTS RULESOmittedChapter V

Rule 41 of the Patents Rules, 2003

Omitted provision

About 3 min read Last reviewed 19 August 2026 Chapter V — Exclusive Marketing Rights (Omitted)
In one line

One of the omitted exclusive marketing rights rules; the scheme it served required approvals and a patent obtained outside India.

Official legal text

Official text — Rule 41, the Patents Rules, 2003 Official source ↗
This provision has been omitted.
Indian drafting practice deletes a provision by omitting it, not by closing the gap. Renumbering would break thousands of existing citations, so the number is retained with a note. Records made while the provision was in force still cite it, which is the main reason this page exists.

Treat this page as a guide. The provision as officially published, along with the Gazette notifications that apply to it, remains the governing text and overrides any simplification here.

What this rule requires, step by step

The exclusive marketing rights scheme was unusual because it depended heavily on things that happened outside India. To qualify, an applicant generally had to point to a patent granted for the same invention in another convention country after the beginning of 1995, to approval to sell the article in that country, and to approval to sell it in India. The chapter of the Patents Rules that this rule belonged to gave the Controller and the applicant a way to place that material on record and have it considered.

The design tells you who the scheme was really for. An applicant needed a foreign patent and two separate marketing approvals, which in practice meant a large originator company rather than an Indian start-up or a university laboratory. When the Patents (Amendment) Act, 2005 introduced product patents for medicines and agricultural chemicals, this externally anchored arrangement was no longer needed and was omitted along with its rules. Today an Indian applicant in these fields is examined on the merits of the invention itself, and no foreign grant or foreign approval is a precondition for protection.

Why this rule matters

Who it affects

Anyone comparing the pre-2005 transitional scheme with the patent system that replaced it.

When it matters

Only for historical analysis of rights sought or granted before the 2005 amendment.

What it creates

Nothing now. It formed part of the procedure for an abolished transitional right.

If it is ignored

Assuming, wrongly, that Indian patent protection still depends on a foreign grant or a foreign approval.

How it works in practice

Worked example

A comparison drawn for a board

The board of a Hyderabad generics company asked its head of intellectual property to explain, in one slide, how India's rules had changed since the company was founded in 2001. She built a two-column table. In the old column she wrote that the only exclusivity available for a new medicine depended on a patent granted abroad, an approval to sell abroad and an approval to sell in India, and that it reached only selling and distributing the product. In the new column she wrote that a patent is available on the invention itself, judged on novelty, inventive step and the statutory exclusions, and that it gives the full set of rights for twenty years from the filing date. A director asked whether the old route was still open to competitors. She showed him the chapter of the Patents Rules, every number in it marked omitted, and said that the old route closed in 2005 for everybody.

Simplified illustration only. Actual legal outcomes depend on the facts.

Key points to remember

  • The abolished scheme relied on a foreign patent and marketing approvals rather than on Indian examination.
  • That design suited large originator companies more than domestic innovators.
  • Indian patent protection today depends on the invention meeting Indian statutory tests, not on foreign grants.

Connected provisions

The Patents Rules supply procedure and the Patents Act supplies power. This page covers the procedure, and the sections that give the Controller or the applicant the underlying right or duty are grouped separately so you can move between the two.

Forms, deadlines and fees

Fees

This site does not carry a fee table. The First Schedule to the Patents Rules is the source, the rates vary with the applicant's category and with the mode of filing, and a figure quoted second-hand goes out of date quietly. How Indian patent fees work.

Related judgments

You will not find case summaries under this heading today. Each one must pass a legal review before it appears, and that work has not been completed for this provision. If you are researching decided cases, use a law report or a court database in the meantime. How case notes are prepared.

Questions people ask about Rule 41

Did India once require a foreign patent before granting exclusivity?

For the transitional exclusive marketing rights scheme, yes in substance. The applicant had to show a patent granted in another convention country after the start of 1995, together with approval to sell the article there and approval to sell it in India. That was a feature of the bridge arrangement, not of Indian patent law generally. A patent application in India has always been examined on its own merits, and a foreign grant has never been a condition of obtaining an Indian patent.

What replaced exclusive marketing rights in India?

Ordinary product patents. From the start of 2005, patents became available for medicines and agricultural chemical products, and applications that had been held since 1995 were taken up for examination. The replacement is stronger and broader: a patent runs for twenty years from the filing date and covers making, using, offering for sale, selling and importing, subject to the safeguards in the Act such as compulsory licensing and the grounds of revocation.

Comparing Indian patent rules before and after 2005?

MYCrave Consultancy explains how the current Indian regime applies to life sciences and agrochemical portfolios.

You will be speaking with MYCrave Consultancy & Services, the firm that operates this platform. General questions are answered free; matter‑specific work is quoted before anything is done.